Laparoscopic cholecystectomy for gallbladder polyp: looking for a clear indication and value
Editorial

Laparoscopic cholecystectomy for gallbladder polyp: looking for a clear indication and value

Francesco Taliente, Pietro Mascagni

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Correspondence to: Pietro Mascagni, MD. Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Via della Pineta Sacchetti, 217, 00168 Rome, Italy. Email: pietro.mascagni@unicatt.it.

Provenance and Peer Review: This is an invited article commissioned by the Editorial Office, Digestive Medicine Research. The article did not undergo external peer review.

Comment on: Ryong H, Jang GC, Ryu DM, et al. Laparoscopic cholecystectomy for gallbladder polyp is significant in the prevention of gallbladder cancer? Dig Med Res 2019;2:32.


Received: 10 March 2020; Accepted: 24 March 2020; Published: 30 June 2020.

doi: 10.21037/dmr.2020.03.03


We read with interest the article by Ryong and colleagues on the use of laparoscopic cholecystectomy (LC) as prevention for gallbladder cancer. The manuscript focuses on the accidental discovery of gallbladder cancer following LC for gallbladder polyp and the occurrence of postcholecystectomy syndrome. The Pyongyang group present their experience with 292 LC performed for gallbladder polyps reporting a 7.2% incidence of malignant lesions and a rate of postcholecystectomy syndrome of 18.8%. They further note that incidence of malignancies rises with the age of patient and the size of polyps. However, the authors correctly point out that in their series 1.4% of polyp under 5 mm were malignant.

The indications to LC for gallbladder cancer prevention are still a matter of discussion. Gallbladder polyp size and patient’s age are known risk factors and have been used for prophylactic LC indications (1). LC is commonly indicated when the polyp size is greater than 10 mm, however this threshold lacks evidences and it is being discussed (1,2). Indeed, in this Korean series 3 patients with smaller polyps presented a malignancy. To define the value of prophylactic LC following the finding of gallbladder polyps a comprehensive analysis of risks, costs and benefits is needed (3). This is much behind the scope of the manuscript by Ryong and colleagues.

A number of interesting questions arise from reading their paper. How does the polyp size correlate with histopathologic staging? LC alone is considered adequate for patients T1a whilst T1b/T2 cancers should undergo extended cholecystectomy (removal of a rim of liver of 2 cm from the gallbladder bed) (4). Estimating the risk of a certain histopathologic stage from the polyp size could thus offer surgeons an actionable information. Furthermore, should we accept the concept of diagnostic LC? In the presented series 191 patients with no symptoms underwent LC because of the incidental finding of gallbladder polyps. It is true that up to now diagnostics have failed to discriminate between true and false polyps and, more importantly, between malignant and benign lesions (2). However, we believe that further research on risks factors and optimal non operative management of gallbladder polyps (5) should be encouraged to prevent surgeries on asymptomatic patients.

In conclusion, we thank Ryong et al. for disclosing their experience that certainly adds interesting observations to a topic in need of more high-quality evidences.


Acknowledgments

Funding: None.


Footnote

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/dmr.2020.03.03). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Wennmacker SZ, van Dijk AH, Raessens JHJ, et al. Polyp size of 1 cm is insufficient to discriminate neoplastic and non-neoplastic gallbladder polyps. Surg Endosc 2019;33:1564-71. [Crossref] [PubMed]
  2. McCain RS, Diamond A, Jones C, et al. Current practices and future prospects for the management of gallbladder polyps: A topical review. World J Gastroenterol 2018;24:2844-52. [Crossref] [PubMed]
  3. Mascagni P, Eberspacher C, Saraceno F, et al. Routine pathology examination in the era of value-based healthcare: the case of haemorrhoids specimens. Updates Surg 2020;72:83-8. [Crossref] [PubMed]
  4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. Version 2. 2016.
  5. Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps: Joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery - European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol 2017;27:3856-66. [Crossref] [PubMed]
doi: 10.21037/dmr.2020.03.03
Cite this article as: Taliente F, Mascagni P. Laparoscopic cholecystectomy for gallbladder polyp: looking for a clear indication and value. Dig Med Res 2020;3:14.